Frederik A Verburg

11PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 30, 2026
Prognostic value of volume-based metabolic parameters of [18F]FDG PET/CT in anaplastic thyroid carcinoma.

|Jan 07, 2026
The malignancy risk of thyroid incidentalomas detected by [18F]FDG PET/CT lower than expected: a nationwide observational study in the Netherlands.

Hannelore I Coerts, Folkert J van Kemenade, Tessa M van Ginhoven

|Nov 07, 2025
In medio stat virtus: towards an evidence rather than dogma based discussion on indicating post-operative I-131 therapy for differentiated thyroid carcinoma.

Frederik A Verburg, Luca Giovanella

|Nov 10, 2023
Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selection.

Frederik A Verburg, Erik de Blois, Stijn Koolen

|Jul 03, 2023
The EANM guideline on radioiodine therapy of benign thyroid disease.

Alfredo Campennì, Anca M Avram, Frederik A Verburg

|Oct 20, 2022
Long-term predictive value of highly sensitive thyroglobulin measurement.

Larissa R Bögershausen, Luca Giovanella, Thomas Stief

Pageof 2

Frequent Collaborators

1 joint publications

Luca Giovanella